Enlarged Prostate
6
0
1
4
Key Insights
Highlights
Success Rate
80% trial completion
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 39/100
16.7%
1 terminated out of 6 trials
80.0%
-6.5% vs benchmark
50%
3 trials in Phase 3/4
50%
2 of 4 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 4 completed trials
Clinical Trials (6)
Laser Prostatectomy Database and Registry
3D Rotational CT Angiogram With Embolization Guidance and CBCT in Prostatic Artery Embolization
A Trial of PROSCAR (Finasteride) Versus Placebo in Men With an Initial Negative Prostate Biopsy
A Study of Tadalafil Use With Finasteride in Men With Enlarged Prostates and Urinary Symptoms
Phase 2 Study of NX-1207 for the Treatment of Benign Prostatic Hyperplasia (BPH) (Enlarged Prostate)
Study of the Efficacy and Safety of Lonidamine for the Treatment of Symptomatic Benign Prostatic Hyperplasia